IMCR
Immunocore Holdings PLC - ADR

507
Mkt Cap
$1.65B
Volume
91,023.00
52W High
$39.33
52W Low
$23.15
PE Ratio
-79.42
IMCR Fundamentals
Price
$32.23
Prev Close
$32.85
Open
$33.15
50D MA
$33.89
Beta
0.74
Avg. Volume
307,594.33
EPS (Annual)
-$1.02
P/B
4.28
Rev/Employee
$629,477.75
Loading...
Loading...
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
493

Frequently Asked Questions

What is Market Cap of Immunocore Holdings plc - ADR?
What is the 52-week high for Immunocore Holdings plc - ADR?
What is the 52-week low for Immunocore Holdings plc - ADR?
What is Immunocore Holdings plc - ADR stock price today?
What was Immunocore Holdings plc - ADR stock price yesterday?
What is the PE ratio of Immunocore Holdings plc - ADR?
What is the Price-to-Book ratio of Immunocore Holdings plc - ADR?
What is the 50-day moving average of Immunocore Holdings plc - ADR?
How many employess does Immunocore Holdings plc - ADR has?

Latest IMCR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.